secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mineralys Therapeutics, Inc. (MLYS)
CIK:        0001933414
Form:       8-K
Filed at:   2026-10-19T20:37:08+00:00
Accession:  0001933414-26-000125
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4.1-flash:cloud@v2

Mineralys Therapeutics adds Kristine Peterson and Lonnel Coats to board, expanding to nine directors
--------------------------------------------------------------------------------

- Board appointed Kristine Peterson and Lonnel Coats effective Oct. 19, 2026, increasing board size from seven to nine directors.
- Peterson named Class I director with term expiring at 2027 annual meeting and Audit Committee member; Coats Class II with term expiring at 2028 annual meeting and Compensation Committee member.
- Each received on Oct. 19, 2026 an option for 16,600 shares vesting monthly over three years and an RSU award for 12,400 shares vesting annually over three years.
- Board determined both satisfy Nasdaq independence requirements; no arrangements or Item 404(a) related-party transactions disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1933414/000193341426000125/0001933414-26-000125-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1933414/000193341426000125/mlys-20261016.htm
  HTML page:      https://secwatch.observer/filing/0001933414-26-000125

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer